Quantcast

Latest Anal cancer Stories

2014-04-30 16:29:50

Grant Earmarked for Trial Drug Aimed at Treatment of Anal Cancer LOS ANGELES, April 30, 2014 /PRNewswire/ -- The Farrah Fawcett Foundation (FFF) has presented a $50,000 grant to the Brown University Oncology Research Group (BrUOG) for "BrUOG 276: A Phase II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer," it was announced by Alana Stewart, President of The FFF. The grant will allow for the continued coordination and management of this novel...

2014-04-23 12:30:36

LONDON, April 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/human_papillomavirus_hpv_associated_cancer_global_clinical_trials_review_h1_2014.html Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Human papillomavirus (HPV)...

2014-04-17 15:37:43

Texas researchers recommend new early colorectal cancer screening guidelines for young cervical cancer survivors Researchers at the University of Texas Medical Branch at Galveston are the first to recommend that young women treated with radiation for cervical cancer should begin colorectal cancer screening earlier than traditionally recommended. The UTMB researchers, finding a high incidence of secondary colorectal cancers among cervical cancer survivors treated with radiation, offer...

2014-04-08 00:22:15

Research efforts will investigate approaches to develop novel immune therapies for HPV-associated cancers SAN DIEGO, April 7, 2014 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) and the Farrah Fawcett Foundation, along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announced the formation of a research team dedicated to HPV-related cancers during a press event today at the AACR Annual Meeting 2014, held here April 5-9. The HPV and Anal Cancer...

2014-02-11 08:33:33

AMSTERDAM, February 11, 2014 /PRNewswire/ -- - SynCo's live microbial track record, GMP scale-up and commercial manufacturing capabilities will facilitate the advancement of Advaxis' ADXS-HPV program - SynCo Bio Partners B.V. [http://www.syncobiopartners.com ], a leading services provider for GMP manufacturing of live microbial vaccines and biotherapeutics today announces that they have entered into a long term manufacturing collaboration with Advaxis, Inc....

2014-01-08 12:29:02

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:MarketVIEW: HPV therapeutic vaccinesHuman papilloma viruses (HPV) members of the papillomaviridae family are extremely common with an estimated worldwide prevalence of ~11-12%. Although nearly all sexually-active men and women acquire the virus at some point in their lives, most infections are asymptomatic and self-limiting; with 90% clearing within 2 years. High risk forms of HPV (16/18)...

2013-12-03 13:48:07

Human papillomavirus, or HPV, which can cause cervical cancer in women, is also known to cause anal cancer in both women and men. Now, a study led by researchers at the UCLA School of Nursing has found that older HIV-positive men who have sex with men are at higher risk of becoming infected with the HPVs that most often cause anal cancer. The researchers also report that smoking increases the risk of infection with specific types of HPV among both HIV-infected and uninfected older men by...

2013-11-26 13:40:27

Barriers to human papillomavirus (HPV) vaccination among adolescents in the U.S. range from financial concerns and parental attitudes to social influences and concerns about the vaccination's effect on sexual behavior, according to a review of the available medical literature published by JAMA Pediatrics, a JAMA Network publication. HPV vaccine coverage among teenagers has increased since the vaccine was licensed in 2006 but it still remains low compared with other recommended...

HPV vaccine effective in one dose
2013-11-04 11:44:37

Brett Smith for redOrbit.com - Your Universe Online An HPV vaccine that guards against cervical cancer was shown to be effective in just one dose, instead of the recommended three, according to a new study published by the journal Cancer Prevention Research. The study researchers found that one dose of the vaccine for human papillomavirus (HPV), the disease known to cause cervical cancer, established antibodies that remained stable in the blood for four years. The team said their study was...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related